Alnylam could get contract for avian flu drug

04/13/2005 | Reuters

Alnylam Pharmaceuticals is in talks with U.S. officials about developing an avian flu drug based on the company's gene-silencing technology. The Cambridge-based company's chief executive said he hopes officials will make a decision later this year on a contract to produce the drug for a government stockpile.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Vice President, Idaho Regional Director
Boise, ID
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations